Acta Endoscopica

, Volume 46, Issue 5, pp 324–329 | Cite as

Endoscopie et obésité

Videodigest
  • 63 Downloads

Endoscopy and obesity

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Branche J, Vedrenne B. Gestion des complications de la chirurgie bariatrique. Acta Endoscopica 2015;45:240–5.CrossRefGoogle Scholar
  2. 2.
    Vanbiervliet G, Gonzalez JM, Barthet M. Endoscopic management of bariatric surgery complications. Acta Endoscopica 2016;46:214–20.CrossRefGoogle Scholar
  3. 3.
    Konopko-Zubrzycka M, Baniukiewicz A, Wróblewski E, et al. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab. mai 2009;94:1644–9.CrossRefGoogle Scholar
  4. 4.
    Nikolic M, Boban M, Ljubicic N, et al. Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency: ghrelin and leptin changes in relation to obesity treatment. Obes Surg 2011;21:1597–604.CrossRefPubMedGoogle Scholar
  5. 5.
    Martinez-Brocca MA, Belda O, Parejo J, et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg 2007;17:649–57.CrossRefPubMedGoogle Scholar
  6. 6.
    Mion F, Napoléon B, Roman S, et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in nonmorbid obese patients. Obes Surg 2005;15:510–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Mathus-Vliegen EM, Eichenberger RI. Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg 2014; 24:85–94.CrossRefPubMedGoogle Scholar
  8. 8.
    Mathus-Vliegen EM, de Groot GH. Fasting and meal-induced ccK and PP secretion following intragastric balloon treatment for obesity. Obes Surg 2013;23:622–33.CrossRefPubMedGoogle Scholar
  9. 9.
    Layec S, Val-Laillet D, Heresbach D, Malbert CH. Gastric tone, volume and emptying after implantation of an intragastric balloon for weight control. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 2010;22:1016–21.CrossRefGoogle Scholar
  10. 10.
    Mathus-Vliegen EM. Endoscopic treatment: the past, the present and the future. Best Pract Res Clin Gastroenterol 2014;28:685–702.CrossRefPubMedGoogle Scholar
  11. 11.
    Van Hee R, Van Wiemeersch S, Lasters B, Weyler J. Use of antiemetics after intragastric balloon placement: experience with three different drug treatments. Obes Surg 2003;13:932–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Machytka E, Chuttani R, Bojkova M, et al. ElipseTM, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study. Obes Surg 2016;26:512–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and metaanalysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015;82:425–38.CrossRefPubMedGoogle Scholar
  14. 14.
    Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond) 2006;30:129–33.CrossRefGoogle Scholar
  15. 15.
    Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatmentresistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61:19–27.CrossRefPubMedGoogle Scholar
  16. 16.
    Farina MG, Baratta R, Nigro A, et al. Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. Obes Surg 2012;22:565–71.CrossRefPubMedGoogle Scholar
  17. 17.
    Genco A, Cipriano M, Bacci V, et al. Intragastric balloon followed by diet vs intragastric balloon followed by another balloon: a prospective study on 100 patients. Obes Surg 2010;20:1496–500.CrossRefPubMedGoogle Scholar
  18. 18.
    De Castro ML, Morales MJ, Del Campo V, et al. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg 2010;20:1642–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Lecumberri E, Krekshi W, Matía P, et al. Effectiveness and safety of air-filled balloon Heliosphere BAG® in 82 consecutive obese patients. Obes Surg 2011;21:1508–12.CrossRefPubMedGoogle Scholar
  20. 20.
    Zheng Y, Wang M, He S, Ji GJ. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. Transl Med 2015;29:13:246.CrossRefGoogle Scholar
  21. 21.
    Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A metaanalysis. Obes Surg 2008;18:841–6.CrossRefGoogle Scholar
  22. 22.
    Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008;18:1611–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Forlano R, Ippolito AM, Iacobellis A, et al. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010;71:927–33.CrossRefPubMedGoogle Scholar
  24. 24.
    Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004;14:991–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients. Obes Surg 2005;15:1161–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Genco A, López-Nava G, Wahlen C, et al. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg 2013;23:515–21.CrossRefPubMedGoogle Scholar
  27. 27.
    Puglisi F, Antonucci N, Capuano P, et al. Intragastric balloon and binge eating. Obes Surg 2007;17:504–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 2007;3:78–83.CrossRefGoogle Scholar
  29. 29.
    Zerrweck C, Maunoury V, Caiazzo R, et al. Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients. Obes Surg 2012;22:777–82.CrossRefPubMedGoogle Scholar
  30. 30.
    Coffin B. Impact du ballon intragastrique (big) avant chirurgie par by-pass gastrique (bpg) laparoscopique chez des patients ayant une obésité morbide: étude randomisée multicentrique comparant le big à une prise en charge conventionnelle (pcc) (etude bigpom). JFODH 2014;Communication orale réf 397Google Scholar
  31. 31.
    Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 2005;15:864–70.CrossRefPubMedGoogle Scholar
  32. 32.
    Dastis NS, François E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009;41:575–80.CrossRefPubMedGoogle Scholar
  33. 33.
    Dumonceau JM, François E, Hittelet A, et al. Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study. Obes Surg 2010;20:692–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg 2008;18:989–92.CrossRefPubMedGoogle Scholar
  35. 35.
    Gaur S, Levy S, Mathus-Vliegen L, Chuttani R. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc 2015;81:1330–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg 2011;21:1499–507.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Carlsson LM, Peltonen M, Ahlin S, Anveden A. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012;367:695–704.CrossRefPubMedGoogle Scholar
  38. 38.
    Sjöström L, Peltonen M, Jacobson P, Sjöström CD. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56–65.CrossRefPubMedGoogle Scholar
  39. 39.
    Tarnoff M, Rodriguez L, Escalona A, Ramos A. Open label, prospective, randomized controlled trial of an endoscopic duodenaljejunal bypass sleeve vs low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009;23:650–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Schouten R, Rijs CS, Bouvy ND, Hameeteman W. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 2010;251:236–43.CrossRefPubMedGoogle Scholar
  41. 41.
    Gersin KS, Keller JE, Stefanidis D, Simms CS. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007;14:275–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM. An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity 2008;16:2585–92.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Lopez-Nava G, Galvao M, Bautista-Castaño I, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open 2016;4:E222–7.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clin Gastroenterol Hepatol 2015;pii:S1542-3565(15)01714-0.Google Scholar
  45. 45.
    Sharaiha RZ, Kedia P, Kumta N, De Filippis EM. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy 2015;47:164–6.PubMedGoogle Scholar
  46. 46.
    Espinós JC, Turró R, Mata A, et al. Early experience with the Incisionless Operating Platform™ (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg 2013;23:1375–83.CrossRefPubMedGoogle Scholar

Copyright information

© Lavoisier 2016

Authors and Affiliations

  1. 1.service des maladies de l’appareil digestif et de la nutritionHôpital Huriez, CHRU LilleLille cedexFrance
  2. 2.Clinique du TrocadéroParisFrance

Personalised recommendations